Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate.
about
Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeabilityROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells.Phosphorylation of the myosin phosphatase targeting subunit and CPI-17 during Ca2+ sensitization in rabbit smooth muscleRole of serine-threonine phosphoprotein phosphatases in smooth muscle contractilityFormin homology domain protein (FHOD1) is a cyclic GMP-dependent protein kinase I-binding protein and substrate in vascular smooth muscle cellsMolecular mechanism of telokin-mediated disinhibition of myosin light chain phosphatase and cAMP/cGMP-induced relaxation of gastrointestinal smooth muscle.Inhibition of capacitative calcium entry is not obligatory for relaxation of the mouse anococcygeus by the NO/cyclic GMP signalling pathwayMechanism of CGRP-induced relaxation in rat intramural coronary arteriesUrocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calciumRole of Telokin in Regulating Murine Gastric Fundus Smooth Muscle TensionRhoA-mediated Ca2+ sensitization in erectile function.The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activity.Modulation of smooth muscle contractility by CHASM, a novel member of the smoothelin family of proteins.Uncoupling of GPCR and RhoA-induced Ca2+-sensitization of chicken amnion smooth muscle lacking CPI-17.Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation.Inhibitory mechanisms for cross-bridge cycling: the nitric oxide-cGMP signal transduction pathway in smooth muscle relaxation.The role of the calponin homology domain of smoothelin-like 1 (SMTNL1) in myosin phosphatase inhibition and smooth muscle contraction.cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Myosin phosphatase-Rho interacting protein. A new member of the myosin phosphatase complex that directly binds RhoA.M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells.Activation of myosin phosphatase targeting subunit by mitosis-specific phosphorylationRhoA/Rho-kinase and nitric oxide in vascular reactivity in rats with endotoxaemia.Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphataseEndothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine-induced dilation of microvessels.Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells.Altered Expression of Human Smooth Muscle Myosin Phosphatase Targeting (MYPT) Isovariants with Pregnancy and Labor.Regulation of myosin light chain phosphatase and pulmonary arterial relaxation.Differential vasodilation of human placental and myometrial arteries related to myofilament Ca(2+)-desensitization and the expression of Hsp20 but not MYPT1.Systems biology of HBOC-induced vasoconstriction.The promise of inhibition of smooth muscle tone as a treatment for erectile dysfunction: where are we now?Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.Regulation of gastrointestinal motility--insights from smooth muscle biology.Myosin phosphatase isoforms as determinants of smooth muscle contractile function and calcium sensitivity of force production.Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction.A splice variant of the myosin phosphatase regulatory subunit tunes arterial reactivity and suppresses response to salt loadingCross-talk between Rho-associated kinase and cyclic nucleotide-dependent kinase signaling pathways in the regulation of smooth muscle myosin light chain phosphatase.Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation.Role of L-type calcium channels and PKC in active tone development in rabbit coronary artery.Mechanisms involved in the regulation of bovine pulmonary vascular tone by the 5-HT1B receptor.Mechanisms of cGMP-dependent mesangial-cell relaxation: a role for myosin light-chain phosphatase activation.
P2860
Q24317362-A77AA133-599D-4A24-BADC-9EA75124EB04Q24646579-3EB8AD7B-60AE-4EAA-A790-3003AA3A7798Q24657236-9829C6B2-8DBE-48D1-85C3-E6B6FA9CC53CQ27693957-2CE836BA-0883-4C37-B9FA-1790E569926BQ28253470-A63EA005-5ACF-4F58-940C-80F537F3F177Q28265662-77432579-D3F6-4BFC-ABC7-F5ED40C0CB81Q28349657-B8E48A68-74E9-4F17-8655-E4E7F6E9A3C4Q28360164-667D20D1-151B-4490-B5B8-B42B87DC7AD8Q28365441-6F0C0BE4-24D6-4567-AB5A-FFB6D4E796A0Q30278873-66B0350D-3B46-48A4-BB1F-D122BDD7BBA7Q30309468-54F899FF-F450-4488-99B9-62A034CCD4E5Q30426930-188F486D-AF41-4C85-AEBC-157C34C87256Q30434302-C9E0D525-47A3-4C9F-8B37-BA606BD7CB65Q30435309-ADBAB1B1-3AC5-4BF9-8306-B542B72D1AEEQ30439447-A5CBAC52-9E51-4908-B13E-70271F66A5F0Q30473009-6E6F29A5-4109-4F55-8933-F469F97A9794Q33758291-6F19D1E6-CA6B-4E38-BF97-2C41B2B4B0DEQ34244951-A1EB6B4E-318C-4DFD-AD8C-6BFBFB4BB860Q34264656-F2B897A7-ECA5-4296-83BF-3C47E9D1A2FAQ34463849-8EC586C0-02FB-4E16-817B-AE4D3DE97E89Q34502458-BBA89DF5-FAEB-4777-A23F-0C55086EBB77Q34606734-098A3585-3807-4ED4-9369-F86A1B4A145FQ35026712-36049797-D778-4AFA-8CC5-D4BC29E533EFQ35041470-8C42A72B-81C0-40D4-ABB1-4FEC8086228CQ36114698-CCA716A0-1720-431B-A5FF-962E7C8CA4E7Q36178519-DBF80BF9-5097-4AED-8D72-EC30957F0DEDQ36333429-0B0334F8-77CF-4E2D-A57E-5C3B977CB6F7Q37272271-C9D702C4-BDED-412B-A7D5-DD4E0326B9F5Q37897234-134927F7-D9B8-4F3F-8DA0-E621557B7D23Q37942765-DB77F765-ED31-4817-BF88-943EE2511DA6Q37997101-9D7828E0-CBA3-4F21-B163-92AC4E238F3EQ38042365-2A436803-85C9-4889-961D-31FCDAD1D267Q38151237-9915D4C3-7396-450C-922A-32600215EFBFQ39162238-81B1D047-CDA8-4FA6-A9AE-D07A45494EA1Q42109947-433F56B4-2309-446D-873C-2ABA85220794Q42413454-2D8270E7-655A-4E41-A1BD-75BF55E3C592Q42507586-E772DF79-18F9-46D9-9EF1-8BCA2CFE05BEQ42507887-D07E27E4-2A18-4418-831E-0A4F0D408CEDQ42914141-EDBAD59B-4682-422B-9186-E79E6EF74DEAQ42939926-8DE1B6BA-05F7-464C-8F00-E7E2434E6D14
P2860
Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Cyclic GMP-dependent stimulati ...... myosin light chain phosphate.
@en
Cyclic GMP-dependent stimulati ...... myosin light chain phosphate.
@nl
type
label
Cyclic GMP-dependent stimulati ...... myosin light chain phosphate.
@en
Cyclic GMP-dependent stimulati ...... myosin light chain phosphate.
@nl
prefLabel
Cyclic GMP-dependent stimulati ...... myosin light chain phosphate.
@en
Cyclic GMP-dependent stimulati ...... myosin light chain phosphate.
@nl
P2093
P356
P1476
Cyclic GMP-dependent stimulati ...... myosin light chain phosphate.
@en
P2093
P304
P356
10.1006/BBRC.1996.0460
P407
P577
1996-03-01T00:00:00Z